pyrvinium has been researched along with thiabendazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortinas de Nava, C; Galindo-Prince, OC; Hennig, UG; Savage, EA; von Borstel, RC | 1 |
| Kobayashi, J; Sato, Y; Shiroma, Y; Takara, M; Toma, H | 1 |
2 other study(ies) available for pyrvinium and thiabendazole
| Article | Year |
|---|---|
A comparison of the genetic activity of pyrvinium pamoate with that of several other anthelmintic drugs in Saccharomyces cerevisiae.
Topics: Anthelmintics; Cell Cycle; Gene Conversion; Mebendazole; Mitosis; Mutagenicity Tests; Piperazine; Piperazines; Pyrantel Pamoate; Pyrvinium Compounds; Recombination, Genetic; Saccharomyces cerevisiae; Thiabendazole; Time Factors | 1987 |
Application of enzyme immunoassay for postchemotherapy evaluation of human strongyloidiasis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anthelmintics; Antibodies, Helminth; Enzyme-Linked Immunosorbent Assay; Feces; Female; Humans; Male; Middle Aged; Pyrvinium Compounds; Strongyloides stercoralis; Strongyloidiasis; Thiabendazole | 1994 |